Lung cancer trial aims to extend survival with CyberKnife boost
NCT ID NCT06627738
First seen Jan 05, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study tests whether adding a focused radiation boost (CyberKnife) after standard chemotherapy and radiation can help people with locally advanced non-small cell lung cancer live longer without the disease getting worse. About 42 adults with stage III lung cancer that cannot be surgically removed will receive the extra radiation. The main goal is to see how many patients remain progression-free after 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Antoine Lacassagne
RECRUITINGNice, 06000, France
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.